| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9790 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.7883 |
| P-glycoprotein Substrate | Substrate | 0.5482 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8399 |
| Non-inhibitor | 0.9315 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6931 |
| Distribution |
| Subcellular localization | Mitochondria | 0.3957 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8277 |
| CYP450 2D6 Substrate | Non-substrate | 0.7983 |
| CYP450 3A4 Substrate | Non-substrate | 0.7177 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5000 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8592 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8915 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6343 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9413 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7783 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.5000 |
| Non-inhibitor | 0.7258 |
| AMES Toxicity | Non AMES toxic | 0.9380 |
| Carcinogens | Non-carcinogens | 0.6426 |
| Fish Toxicity | High FHMT | 0.9603 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9971 |
| Honey Bee Toxicity | High HBT | 0.6533 |
| Biodegradation | Not ready biodegradable | 0.5661 |
| Acute Oral Toxicity | III | 0.7017 |
| Carcinogenicity (Three-class) | Non-required | 0.4804 |